The value of BCG and TNF in autoimmunity /

Mostrar otras versiones (1)

"The Value of BCG and TNF in Autoimmunity provides an overview of current research and thinking related to tumor necrosis factor (TNF) induction and the use of the bacillus Calmette-Gu�erin (BCG) vaccine as potential treatment approaches to diverse forms of autoimmunity. BCG, commonl...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: BCG and TNF Signaling in the Treatment and Prevention of Autoimmune Diseases London, England
Otros Autores: Faustman, Denise (Editor )
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: London : Elsevier/Academic Press, [2014]
Temas:
Autoimmune diseases > Immunotherapy.
BCG vaccines > Therapeutic use.
Tumor necrosis factor.
Autoimmunity.
Autoimmune Diseases > therapy
BCG Vaccine > therapeutic use
Autoimmunity
Immunotherapy > methods
Tumor Necrosis Factors
Maladies auto-immunes > Immunoth�erapie.
Auto-immunit�e.
Facteurs de n�ecrose tumorale.
HEALTH & FITNESS > Diseases > General.
MEDICAL > Clinical Medicine.
MEDICAL > Diseases.
MEDICAL > Evidence-Based Medicine.
MEDICAL > Internal Medicine.
Autoimmune diseases > Immunotherapy
BCG vaccines > Therapeutic use
Tumor necrosis factor
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congr�es.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Mycobacteria, immunoregulation, and autoimmunity
  • Prevention of Type 1 Diabetes and its recurrence by immunotherapy with mycobacterial adjuvants
  • Proteasome defects and cytokine signaling on Sjogren's syndrome
  • The protective effect of the BCG vaccine on the development of Type 1 Diabetes in humans
  • Effects of the bacillus Calmette-Gu�erin (BCG) vaccines in the demyelinating disease of the central nervous system
  • TNF, BCG, and the proteasome in autoimmunity: an overview of the pathways & results of a phase I study in Type 1 diabetes
  • Why test BCG in Sj�ogrens syndrome?
  • Celiac disease as a model disorder for testing autoimmune therapeutics
  • Delivering solutions and clinical benefits for diseases with small intermediate-size patient populations.

Ejemplares similares